MedTrace Logo

Comparison of the Acute Effects of Chest Physiotherapy Methods Applied in Different Positions in Preterm Newborns

NCT05036603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-09-12

No results posted yet for this study

Summary

Infants in the neonatal intensive care unit (NICU) may be lost due to risks such as being sensitive, frequent exposure to birth complications and being prone to infection. The most common causes of mortality in newborn babies in the world; Complications due to preterm delivery (28%), infections (26%) and perinatal asphyxia (23%) were reported. Respiratory problems are observed in 4-6% of newborns. These problems are also important causes of mortality in the neonatal period. Newborn infants are more likely to have respiratory distress due to difficulties in airway calibration, few collateral airways, flexible chest wall, poor airway stability, and low functional residual capacity.Invasive mechanical ventilation (IMV) is frequently used in the treatment of newborns with respiratory failure. Various ventilation modes and strategies are used to optimize mechanical ventilation and prevent ventilator-induced lung injury. Among the important issues to be considered in newborns connected to mechanical ventilator (MV); Choosing an appropriately sized endotracheal tube to reduce airway resistance and minimize respiratory workload, correct positioning, regular nursing care, chest physiotherapy, sedation-analgesia, and infection prevention are also included.

Conditions

  • Preterm Birth
  • Premature
  • Bronchopulmonary Dysplasia
  • Respiratory Distress Syndrome
  • Mechanical Ventilation Complication
  • Mechanical Ventilation Pressure High
  • Oxygen Toxicity
  • Neonatal Respiratory Failure
  • Atelectasis Neonatal
  • Pneumonia Neonatal
  • Lobar Collapse
  • Chronic Liver Disease
  • Hyaline Membrane Disease

Interventions

OTHER

chest physiotherapy

diffferent chest physiotherapy methods

Sponsors & Collaborators

  • Sanko University

    lead OTHER

Principal Investigators

  • hatice Adiguzel, PhD · Kahramanmaras Sutcu Imam University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
45 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2024-07-30
Completion
2024-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05036603 on ClinicalTrials.gov